BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AiViva BioPharma - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AiViva BioPharma
X-ORIGINAL-URL:https://aiviva.com
X-WR-CALDESC:Events for AiViva BioPharma
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250616
DTEND;VALUE=DATE:20250620
DTSTAMP:20260416T145405
CREATED:20250520T232726Z
LAST-MODIFIED:20250520T232726Z
UID:10000021-1750032000-1750377599@aiviva.com
SUMMARY:AiViva is heading to BIO International 2025
DESCRIPTION:We’re excited to announce that AiViva BioPharma will participate in the BIO International Convention 2025\, which will take place this June in Boston! \nWith three clinical-stage programs and our proprietary JEL® long-acting injectable platform\, AiViva is redefining how therapies are delivered. It focuses drugs precisely where needed\, minimizing systemic exposure\, and extending duration for up to six months. Our pipeline targets multi-billion-dollar markets across oncology\, ophthalmology\, and dermatology\, with accelerated 505(b)(2) regulatory paths and IP protection into the 2040s. \nWe’re actively scheduling partnering meetings with investors\, pharma partners\, and innovators looking to collaborate. \nLet’s meet in Boston and shape the next wave of targeted\, long-acting therapies.   \nAgustin de la Calle\, Vice President of Business Development:   \n\nhttps://www.linkedin.com/in/agustin-de-la-calle-4b0136/\noffice@aiviva.com
URL:https://aiviva.com/event/aiviva-is-heading-to-bio-international-2025/
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2025/05/Discovering-New-Business-Opportunities-1-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250504
DTEND;VALUE=DATE:20250509
DTSTAMP:20260416T145405
CREATED:20250214T013754Z
LAST-MODIFIED:20250306T204100Z
UID:10000018-1746316800-1746748799@aiviva.com
SUMMARY:AiViva BioPharma at ARVO
DESCRIPTION:AiViva BioPharma is excited to present posters at The Association for Research in Vision & Ophthalmology (ARVO) conference in Salt Lake City\, Utah on May 6\, 2025.\nPresentation Number – Posterboard Number: 3782 – B0003 Translation \nAbstract/Presentation Title:  Periocular Administration of AIV007 Demonstrates Depot Formation for Prolonged Drug Release in Rabbits and Humans \nPresentation Type: Poster Session \nSession Number: 363 \nSession Title: Diabetic Macular Edema.  Clinical Research \nSession Date/Times: May 6\, 2025 from 3:30 PM to 5:15 PM \n  \nPresentation Number – Posterboard Number: 3783 – B0004 CLIN Translation \nAbstract/Presentation Title: Periocular Administration of AIV007 in the Treatment of Diabetic Macular Edema: Preliminary Phase 1 Trial Results \nPresentation Type: Poster Session \nSession Number: 363 \nSession Title: Diabetic Macular Edema. Clinical research \nSession Date/Times: May 6\, 2025 from 3:30 PM to 5:15 PM \n  \nIf you attend ARVO 2025\, please stop by and say hello!   We look forward to meeting you.
URL:https://aiviva.com/event/arvo2025/
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2025/02/ARVO-2025.3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250401
DTEND;VALUE=DATE:20250404
DTSTAMP:20260416T145405
CREATED:20250331T185812Z
LAST-MODIFIED:20250331T185812Z
UID:10000022-1743465600-1743724799@aiviva.com
SUMMARY:AiViva Virtual Partnering with RESI EUROPE 2025
DESCRIPTION:AiViva excited to attend workshops and meetings related to Biotech\, MedTech\, healthcare innovation\, cutting-edge technologies and regulatory challenges shaping the industry on how it impacts patient care. \nIf you wish to contact Shane Cerrato\, Vice President\, Business Development\, you may contact him at:  shane@aiviva.com \nLearn more at:  https://resiconference.com/ \n  \n  \n  \n 
URL:https://aiviva.com/event/aiviva-virtual-partnering-with-resi-europe-2025/
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2025/03/Shane-LinkedIn.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250317
DTEND;VALUE=DATE:20250322
DTSTAMP:20260416T145405
CREATED:20250221T234346Z
LAST-MODIFIED:20250303T193351Z
UID:10000019-1742169600-1742601599@aiviva.com
SUMMARY:Join AiViva BioPharma at LSI USA Summit 2025
DESCRIPTION:AiViva partnering with industry-leading executives building Medtech\, from emerging companies\, venture capital and private equity firms to family offices and small business.\nMarch 17th – 21st in Dana Point\, CA\n 
URL:https://aiviva.com/event/join-aiviva-biopharma-at-lsi-usa-summit-2025/
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2025/02/LSI-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250307
DTEND;VALUE=DATE:20250312
DTSTAMP:20260416T145405
CREATED:20250221T234409Z
LAST-MODIFIED:20250221T234409Z
UID:10000016-1741305600-1741737599@aiviva.com
SUMMARY:AiViva at #AAD2025
DESCRIPTION:Darlene Deecher\, Vice President\, Clinical Development\, will be speaking at the American Academy of Dermatology (AAD) Annual Meeting on March 7-11\, 2025 in Orlando\, Florida. \nAAD is the largest\, most influential\, and representative dermatology group in the United States.  It is also the premier dermatology education event of the year led by dermatology experts and the best time to connect with peers and industry leaders.   For more information:  https://www.aad.org/member/meetings-education/am25 \nIf you’d like to connect with Dr. Deecher\, feel free to contact her for an appointment at AAO:  darlene@aiviva.com \n  \n 
URL:https://aiviva.com/event/aiviva-at-aad2025/
LOCATION:Orange County Convention Center\, 9800 International Drive\, Orlando\, FL\, 32819\, United States
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2025/01/PRE-AAD2025-Event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250225
DTEND;VALUE=DATE:20250228
DTSTAMP:20260416T145405
CREATED:20250221T234547Z
LAST-MODIFIED:20250221T234547Z
UID:10000020-1740441600-1740700799@aiviva.com
SUMMARY:AiViva at Biocom California
DESCRIPTION:AiViva attending Global Life Science Partnering & Investor Conference presented by Biocom California.  Location in beautiful LaJolla\, California. \nDates of event:  February 25-27\, 2025 \n 
URL:https://aiviva.com/event/aiviva-at-biocom-california/
LOCATION:The Lodge at Torrey Pines\, 11480 N. Torrey Pines Road\, La Jolla\, CA\, 92037\, United States
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2025/02/BIOCOM-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250113
DTEND;VALUE=DATE:20250117
DTSTAMP:20260416T145405
CREATED:20241211T122912Z
LAST-MODIFIED:20250110T161223Z
UID:10000014-1736726400-1737071999@aiviva.com
SUMMARY:AiViva will be at BIO Partnering
DESCRIPTION:Expecting an exciting week at JPM Week.  BIO 1:1 Partnering offers opportunities to meet senior biotech executives\, business development leaders\, analysts and investors from leading companies around the globe.   Reach out to me at this event to explore strategic partnerships in dermatology.  We are looking forward to meeting you! \n  \nContact info:  shane@aiviva.com or on LinkedIn \nLearn more about the Biotechnology Innovation Organization (BIO):  LINK
URL:https://aiviva.com/event/aiviva-will-be-at-bio-partnering/
LOCATION:San Francisco Marriott Marquis & Virtual\, 80 Mission Street\, San Francisco\, CA\, 94103\, United States
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2024/12/BIO-Partnering-@-JPM-Week.png
ORGANIZER;CN="BIO Partnering":MAILTO:customercare@bio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250113
DTEND;VALUE=DATE:20250117
DTSTAMP:20260416T145405
CREATED:20241206T140848Z
LAST-MODIFIED:20250110T161525Z
UID:10000013-1736726400-1737071999@aiviva.com
SUMMARY:AiViva at 43rd J.P. Morgan Healthcare Conference
DESCRIPTION:  \nDiane Tang-Liu\, CEO and Founder of AiViva BioPharma\, will be attending the many presentations and discussions at the annual J.P. Morgan Healthcare Conference in San Francisco.  If you’re interested in meeting Diane at this event\, contact Shane Cerrato\, VP of Business Development. \nContact info:  shane@aiviva.com \nLinkedIn contact info:  LINK \nPlease note:  This event is by invitation only.  Agenda available to invitees only.
URL:https://aiviva.com/event/aiviva-will-be-at-bio-partnering-2/
LOCATION:The Westin St. Francis\, 335 Powell Street\, San Francisco on Union Square 335 Powell Street\, San Francisco\, 94102\, United States
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2024/12/Event-Diane-@-JPMorgan-Healthcare.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250109T073000
DTEND;TZID=America/Los_Angeles:20250110T140000
DTSTAMP:20260416T145405
CREATED:20250108T182818Z
LAST-MODIFIED:20250108T182818Z
UID:10000015-1736407800-1736517600@aiviva.com
SUMMARY:AiViva Presenting at Octane's Aesthetics Tech Forum
DESCRIPTION:Diane Tang-Liu\, President & CEO of AiViva BioPharma\, Inc.\, will be presenting data on their dermatology asset at the upcoming Aesthetics Tech Forum on January 9\, 2025. \nOctane’s Aesthetics Tech Forum is the premier event for physicians\, industry professionals\, investors\, and entrepreneurs in the aesthetics technology space. \nLearn more at:  https://octaneoc.org/aesthetics-tech-forum/ \n  \n  \n  \n  \n 
URL:https://aiviva.com/event/aiviva-presenting-at-octanes-aesthetics-tech-forum/
LOCATION:Pendry Newport Beach\, 690 Newport Center Drive\, Newport Beach\, CA\, 92660\, United States
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2025/01/ATF-OFFICIAL-GRAPHIC-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241122
DTEND;VALUE=DATE:20241124
DTSTAMP:20260416T145405
CREATED:20240711T024857Z
LAST-MODIFIED:20241115T140540Z
UID:10000007-1732233600-1732406399@aiviva.com
SUMMARY:Ophthalmology Innovation Source (OIS) XIV
DESCRIPTION:AiViva presenting with over 150 companies at OIS XIV Ophthalmology Innovation Summit. \nThis event unites many capital\, clinical\, and corporate leaders presenting clinical insights\, anterior and posterior ophthalmology segments both.   We look forward to learning\, networking and collaborating at OIS Summit.
URL:https://aiviva.com/event/ophthalmology-innovation-source-ois-xiv/
LOCATION:Omni Hotel San Diego\, 675 L Street\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2024/07/OIS-XIV-2024-LOGO.png
ORGANIZER;CN="OIS XIV":MAILTO:ois@healthegy.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241017
DTEND;VALUE=DATE:20241018
DTSTAMP:20260416T145405
CREATED:20240910T035309Z
LAST-MODIFIED:20240913T005254Z
UID:10000010-1729123200-1729209599@aiviva.com
SUMMARY:AiViva Excited to Attend Eyecelerator @ AAO 2024
DESCRIPTION:Eyecelerator @ AAO 2024 \nHeld twice per year\, Eyecelerator conferences provide a full day of KOL-driven programs highlighting industry advancements\, investment trends\, and innovative new products disrupting eye care.  There are valuable opportunities to network and explore new market potentials.  Dozens of company showcases presenting novel clinical treatments and emerging technologies that are shaping the future of ophthalmology and expanded opportunities for audience questions and participation. \nLearn more at:  https://www.eyecelerator.com/ \n  \nAiViva’s Abstract for 2024  \nTitle:  Ocular and Systemic Pharmacokinetic Profiles Following Periocular Administration of AIV007 Gel Formulation \nAuthors: Yi Zhao and Diane DS Tang-Liu \n  \n  \n  \n 
URL:https://aiviva.com/event/aiviva-excited-to-attend-eyecelerator-aao-2024/
LOCATION:McCormick Place\, Chicago\, IL\, United States
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2024/08/pexels-lucianphotography-3566191-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240918
DTEND;VALUE=DATE:20240920
DTSTAMP:20260416T145405
CREATED:20240910T035453Z
LAST-MODIFIED:20240910T035453Z
UID:10000011-1726617600-1726790399@aiviva.com
SUMMARY:MedInvest Biotech & Pharma Investor Conference
DESCRIPTION:AiViva attending the upcoming meeting of the MedInvest Biotech & Pharma Investor Conference will be held in New York City\, NY on September 18-19\, 2024.  \nThe conference will feature two days of company presentations\, panel discussions\, and keynote talks. Both in-person and virtual meetings will be taking place during the two days of the conference. The presenting companies are developing and/or commercializing technologies across a broad spectrum of indications\, including oncology\, immunology\, neurology\, cardiology\, diabetes\, infectious diseases\, pulmonary diseases\, autoimmune diseases\, respiratory diseases\, urology\, endocrinology\, dermatology\, pain management\, and many others. \n 
URL:https://aiviva.com/event/medinvest-biotech-pharma-investor-conference/
LOCATION:O’Melveny\, 1301 6th Avenue\, New York\, NY\, 10019\, United States
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2024/08/MedInvent-Graphic-1.jpg
ORGANIZER;CN="MedInvent":MAILTO:investors@medinvestconferences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240911
DTEND;VALUE=DATE:20240913
DTSTAMP:20260416T145405
CREATED:20240910T065038Z
LAST-MODIFIED:20240910T065038Z
UID:10000009-1726012800-1726185599@aiviva.com
SUMMARY:AiViva BioPharma at 2024 LSX World Congress USA
DESCRIPTION:Reach out to Shane at this meeting\, or through LinkedIn\, to explore strategic partnerships in ophthalmology and/or dermatology. \n  \nFind out more: https://informaconnect.com/lsx-world-congress-usa/
URL:https://aiviva.com/event/aiviva-biopharma-at-2024-lsx-world-congress-usa/
LOCATION:Hynes Convention Centre\, 900 Boylston Street\, Boston\, MA\, 02115\, United States
ATTACH;FMTTYPE=image/png:https://aiviva.com/wp-content/uploads/2024/08/Shane-LinkedIn-Post.png
ORGANIZER;CN="LSX World Congress USA":MAILTO:melanie@lsxleaders.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240725
DTEND;VALUE=DATE:20240729
DTSTAMP:20260416T145405
CREATED:20240706T081448Z
LAST-MODIFIED:20240711T024929Z
UID:10000006-1721865600-1722211199@aiviva.com
SUMMARY:AiViva at 2024 Bio Asia-Taiwan
DESCRIPTION:The Conference will focus on five major areas: Innovation Forum\, Investment Summit\, Regional Collaboration Forum\, Company Presentations\, and Satellite Symposia. \nBIO Asia–Taiwan 2024 will again feature the renowned BIO One-on-One Partnering™ platform\, an easy-to-use online meeting scheduling system to search for and identify potential partners\, collaborators\, investors and in- and out-licensing opportunities. Face-to-face meetings will be held over private and secure video links 24 hours a day during the event period. With over 5\,500+ meeting requests made via the system during BIO Asia–Taiwan 2023 and with an 68% increase in meetings scheduled over the year before\, partnering is again expected to be a highly popular activity.  \nBIO Asia–Taiwan 2024 will showcase Taiwan’s growing digital advantage in the biomed sector and highlight advances in biotech\, pharmaceutical\, medical devices\, precision medicine\, AI applications\, ICT\, IoT technologies\, and new healthcare/medical investment opportunities. \nAgenda:  BIO Asia–Taiwan 2024 亞洲生技大會
URL:https://aiviva.com/event/aiviva-biopharmas-ceo-diane-tang-liu-will-present-on-july-25-2024/
LOCATION:Bio Asia-Taiwan 2024\, Taipei Nangang Exhibition Center\, Hall 2 (TaiNEX2 7F)\, Taipei\, Taiwan
ATTACH;FMTTYPE=image/jpeg:https://aiviva.com/wp-content/uploads/2024/06/banner_W1000xH200.jpg
ORGANIZER;CN="Bio Asia-Taiwan 2024":MAILTO:register@taiwanbio.org.tw
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240505
DTEND;VALUE=DATE:20240510
DTSTAMP:20260416T145405
CREATED:20240219T155225Z
LAST-MODIFIED:20240413T014607Z
UID:10000005-1714867200-1715299199@aiviva.com
SUMMARY:AiViva BioPharma Presents Two Abstracts/Presentations at ARVO 2024
DESCRIPTION:  \nAiViva BioPharma is excited to present two Abstract/Presentations at The Association for Research in Vision & Ophthalmology (ARVO) conference in Seattle\, Washington on May 5 and May 6\, 2024.\nThe following will be presented by AiViva executives: \nPresentation Number – Posterboard Number: 237 – B0300 \nAbstract/Presentation Title: Periocular injection of AIV007 in the Treatment of Macular Edema due to Neovascular Age-related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME): Preliminary Results of the Phase 1 Clinical Trial \nPresenter:  Yi Zhao\, MD\, PhD\nPresentation Type: Poster Session\nSession Number: 108\nSession Title: AMD-1 (anti-VEGF)\nSession Date/Times: May 5\, 2024 from 8:00 AM to 9:45 AM \n  \nPresentation Number – Posterboard Number: 1946 – B0309\nAbstract/Presentation Title: AIV007 Is a Potent Anti-angiogenic Agent with Anti-fibrotic Effect \nPresenter:  Yi Zhao\, MD\, PhD\nPresentation Type: Poster Session\nSession Number: 225\nSession Title: AMD new drugs\, delivery systems and mechanisms of action \nSession Date/Times:  May 6\, 2024 from 8:30 AM to 10:15 AM \n \nIf you attend ARVO 2024\, please stop by and say hello!   We look forward to meeting you. \nAbout ARVO:  https://www.arvo.org/globalassets/arvo/about/press-room/arvo-fact-sheet.pdf \nARVO Schedule:  https://www.arvo.org/globalassets/annual-meeting/arvo-2024/2024-schedule-at-a-glance.pdf \n 
URL:https://aiviva.com/event/aiviva-biopharma-presents-two-abstracts-presentations-at-arvo-2024/
LOCATION:ARVO 2024\, 705 Pike Street\, Seattle\, WA\, 98101-2310\, United States
ATTACH;FMTTYPE=image/webp:https://aiviva.com/wp-content/uploads/2024/02/Poster-design.webp
ORGANIZER;CN="ARVO 2025":MAILTO:arvo@arvo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240228T153000
DTEND;TZID=UTC:20240228T170000
DTSTAMP:20260416T145405
CREATED:20240213T082517Z
LAST-MODIFIED:20240213T082517Z
UID:10000004-1709134200-1709139600@aiviva.com
SUMMARY:AiViva BioPharma presents at the Global Life Science Partnering & Investor Conference
DESCRIPTION:AiViva BioPharma presents at the Global Life Science Partnering & Investor Conference presented by Biocom California.  Location at The Lodge at Torrey Pines at 4:00 p.m.  \nSee links below. \n 
URL:https://aiviva.com/event/aiviva-biopharma-presents-at-the-global-life-science-partnering-investor-conference/
LOCATION:Global Life Science Partnering & Investor Conference\, THE LODGE AT TORREY PINES\, LaJolla\, CA\, United States
ATTACH;FMTTYPE=image/webp:https://aiviva.com/wp-content/uploads/2024/02/Biocom-Feb.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220507
DTEND;VALUE=DATE:20220508
DTSTAMP:20260416T145405
CREATED:20221006T162249Z
LAST-MODIFIED:20221006T172106Z
UID:10000001-1651881600-1651967999@aiviva.com
SUMMARY:National Taiwan University Conference
DESCRIPTION:CEO & President\, Dr. Diane Tang-Liu\, will be keynote speaker on May 7\, 2022\, at National Taiwan University (NTU). Recognized as a Distinguished NTU School of Pharmacy Alumnus\, Dr. Tang-Liu’s presentation topic is “Transforming the Standard of Care for Age-Related Macular Degeneration to Address Unmet Medical Needs.” \nDr. Tang-Liu serves as a Scientific Advisor to Perfuse Therapeutics\, Taiwan’s Supra Integration\, and Incubation Center\, Academia Sinica\, and the National Taiwan University-Stanford University SPARK program. In 2009\, she received a Distinguished Alumni Achievements Award from the School of Pharmacy\, National Taiwan University\, She was elected Fellow of American Association of Pharmaceutical\nScientists and American College of Clinical Pharmacology. Diane received B.S. in Pharmacy from National Taiwan University\, and Ph.D. in Pharmaceutical Chemistry from the University of California\, San Francisco.
URL:https://aiviva.com/event/national-taiwan-university-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220505
DTEND;VALUE=DATE:20220506
DTSTAMP:20260416T145405
CREATED:20221006T162317Z
LAST-MODIFIED:20221006T172147Z
UID:10000002-1651708800-1651795199@aiviva.com
SUMMARY:MAGI’s Clinical Research Conference
DESCRIPTION:Dr. Deecher chairing a session on the MAGI’s Clinical Research vConference on May 5\, 2020\, from 2:30-3:30pm ET. Subject matter on “The ‘Tiny Details’ that Can Wreak Havoc with a Protocol. What sponsors\, sites and CROs should look for in a protocol.” #MAGIworld
URL:https://aiviva.com/event/magis-clinical-research-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200427
DTEND;VALUE=DATE:20200428
DTSTAMP:20260416T145405
CREATED:20221006T162402Z
LAST-MODIFIED:20221006T172217Z
UID:10000003-1587945600-1588031999@aiviva.com
SUMMARY:MAGI’s Clinical Research Conference
DESCRIPTION:AiViva participated on the MAGI’s Clinical Research vConference. Dates of conference on April 26-29 and May 3-6\, 2020. Darlene Deecher\, Head of Clinical Development at AiViva\, will be discussing “New Times\, New Solutions: Key Challenges for Small Sponsors” on Tuesday\, April 27\, 11:00-12:00pm ET
URL:https://aiviva.com/event/magis-clinical-research-conference-2/
END:VEVENT
END:VCALENDAR